TREA

97409708 - ECLIPSYS

Follow

Information

  • Trademark
  • 97409708
  • Serial Number
    97409708
  • Registration Number
    7179544
  • Filing Date
    May 13, 2022
    3 years ago
  • Registration Date
    October 03, 2023
    2 years ago
  • Transaction Date
    April 27, 2025
    9 months ago
  • Status Date
    October 03, 2023
    2 years ago
  • Published for Opposition Date
    July 18, 2023
    2 years ago
  • Location Date
    October 03, 2023
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BRACEY, KAREN
  • Attorney Docket Number
    235211200006
    Attorney Name
    Rob LeBlanc
    Law Office Assigned Location Code
    M70
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ECLIPSYS
Case File Statements
  • GS0051: Pharmaceuticals, medicinal and veterinary preparations for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; diagnostic preparations for medical and veterinary use; medicines and biotechnological preparations for medical use for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; biological and chemical reagents for medical use; pharmaceutical drugs for medical purposes for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; none of the aforesaid goods being for the treatment and care of wounds and none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers
  • GS0011: Chemicals for use in science; chemical compositions and agents for use in science; chemical preparations for use in the manufacture of pharmaceutical drugs; biological preparations for use in science; chemicals for biotechnological manufacturing processes; diagnostic preparations used for scientific or research use; reagents used for scientific or research use; proteins in raw material form for scientific or research use; none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers
  • GS0421: Scientific and technological services, namely, scientific analysis, testing, engineering, development, research, and design in the field of drug discovery and the identification and development of pharmaceutical and medicinal preparations; consultancy relating to product research and development in the field of pharmaceutical and medicinal preparations for therapeutic use; research and development in the field of medical diagnostics; biotechnological and chemical testing; research and development in the pharmaceutical, chemical and biotechnological fields; research and development in the field of medicinal preparations; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; none of the aforesaid relating to reagents and chemicals for use in relation to biochemicals, oligonucleotides, oligonucleotide conjugates, DNA primers, DNA, genetic, and oligonucleotide probes, and quenchers
Case File Event Statements
  • 5/17/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/18/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/2/2022 - 3 years ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 6/2/2022 - 3 years ago
    4 - TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Type: TAEA
  • 2/14/2023 - 2 years ago
    5 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 2/14/2023 - 2 years ago
    6 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/14/2023 - 2 years ago
    7 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/14/2023 - 2 years ago
    8 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 2/14/2023 - 2 years ago
    9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/14/2023 - 2 years ago
    10 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 2/15/2023 - 2 years ago
    11 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 2/15/2023 - 2 years ago
    12 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/15/2023 - 2 years ago
    13 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 3/2/2023 - 2 years ago
    14 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/3/2023 - 2 years ago
    15 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/3/2023 - 2 years ago
    16 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/3/2023 - 2 years ago
    17 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/31/2023 - 2 years ago
    18 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/31/2023 - 2 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/1/2023 - 2 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/12/2023 - 2 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/28/2023 - 2 years ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/18/2023 - 2 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/18/2023 - 2 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/3/2023 - 2 years ago
    26 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 10/3/2023 - 2 years ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/22/2025 - 9 months ago
    30 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/22/2025 - 9 months ago
    28 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/22/2025 - 9 months ago
    29 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/22/2025 - 9 months ago
    31 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/22/2025 - 9 months ago
    27 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR